NeurologyLive® Friday 5 — March 4, 2022

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending March 4, 2022.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: ACTRIMS Forum 2022

The NeurologyLive® team is still providing coverage from the Americas Committee for Treatment and Research in Multiple Sclerosis Forum 2022, including video interviews conducted on-site with experts and the latest clinical data readouts and presentations.

2: Rare Disease Day: Updates on Rare Neurological Diseases

In recognition of Rare Disease Day, the NeurologyLive® team offered an extensive update on the state of care and treatment for a wide range of rare neurological diseases, including Kleine-Levin syndrome, amyotrophic lateral sclerosis, cerebral palsy, Lennox-Gastaut syndrome, and more.

3: NeuroVoices: Matthew Schindler, MD, PhD, on Developing a Predictive Model for Chronic Active Lesions in MS

The assistant professor of neurology at the University of Pennsylvania provided insight on a new way to accurately predict chronic active lesion evolution from newly developing MS lesions using 7T MRI, which may be able to help better facilitate treatments that can target these clinically important lesions.

4: Cure Connections: Genetic Testing for SMA in Children and Adolescents

In episode 9 of this of NeurologyLive® Cure Connections series, "The Identification and Evaluation of Suspected Spinal Muscular Atrophy (SMA) in Children and Adolescents During a Telehealth Appointment," Crystal Proud, MD, and Craig Zaidman, MD, discuss the necessity and urgency of genetic testing for SMA in children and adolescents.

5: Tactics for Recognizing, Addressing Stigma in Epilepsy: Joan K. Austin, PhD, RN, FAAN

The Distinguished Professor Emerita at Indiana University School of Nursing spoke on key takeaways for clinicians when it comes to helping tackle stigma, as well as the need to educate patients and their families about the condition overall.